[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group consists of 30 patients, which will recieve the standard regimen of COVID-19 treatment including ramdisvir, interferen and corticosteroids and supplements in addition to dexmedtomidine for sedation. Dexmedtomidine is produced by Elixir Pharmaceutical Company, which is in form of a 200 Micrograms in a 2 millilitres vial. The total time of this study will be 15 days. Evaluation of clinical status of patients will be on 8-hour intervals, based on questionnaire form and variables of the study .", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsControl group: consists of 30 patients,who will receive standard treatment of COVID-19 mentioned as above plus standard sedative treatment regimen which is a fentanyl and morphine pump,including a vial of fentanyl and a vial of morphine and will be injected at a speed of 3-5 millilitre per hour based on the patients need for relaxation.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1878, "treatment_name": "Dexmedetomidine", "treatment_type": "Central nervous system agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]